Zobrazeno 1 - 10
of 152
pro vyhledávání: '"radiotheranostics"'
Autor:
Hiroyuki Suzuki, Kento Kannaka, Mizuki Hirayama, Tomoki Yamashita, Yuta Kaizuka, Ryota Kobayashi, Takahiro Yasuda, Kazuhiro Takahashi, Tomoya Uehara
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 9, Iss 1, Pp 1-12 (2024)
Abstract Background Prostate cancer is a common cancer among men worldwide that has a very poor prognosis, especially when it progresses to metastatic castration-resistant prostate cancer (mCRPC). Therefore, novel therapeutic agents for mCRPC are urg
Externí odkaz:
https://doaj.org/article/1475a9576b644e5ab1ab2131dbba5509
Autor:
Zhenni Wei, Bingyu Li, Xuejun Wen, Vivianne Jakobsson, Peifei Liu, Xiaoyuan Chen, Jingjing Zhang
Publikováno v:
Advanced Science, Vol 11, Iss 30, Pp n/a-n/a (2024)
Abstract Radiotheranostics is a rapidly growing approach in personalized medicine, merging diagnostic imaging and targeted radiotherapy to allow for the precise detection and treatment of diseases, notably cancer. Radiolabeled antibodies have become
Externí odkaz:
https://doaj.org/article/147a7f7400dc4c708c84693f1c2e6cea
Autor:
Mohamed Sallam, Mahan Mohammadi, Frank Sainsbury, Nam-Trung Nguyen, Nobuo Kimizuka, Serge Muyldermans, Martina Benešová-Schäfer
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
PurposeBibliometric and scientometric analyses provide a structured approach to large amounts of data, enabling the prediction of research theme trends over time, the detection of shifts in the boundaries of disciplines, and the identification of the
Externí odkaz:
https://doaj.org/article/03669ef8d1d947ea86b046c66c79e9e6
Autor:
Hongzhang Yang, Xinying Zeng, Jia Liu, Jingchao Li, Yun Li, Qinglin Zhang, Linlin Shu, Huanhuan Liu, Xueqi Wang, Yuanyuan Liang, Ji Hu, Lumei Huang, Zhide Guo, Xianzhong Zhang
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background Radiotheranostics differs from the vast majority of other cancer therapies in its capacity for simultaneous imaging and therapy, and it is becoming more widely implemented. A balance between diagnostic and treatment requirements i
Externí odkaz:
https://doaj.org/article/171d20221cc74601af029e0e77dc904e
Autor:
Panagiotis Kanellopoulos, Adam Mattsson, Ayman Abouzayed, Karim Obeid, Berthold A. Nock, Vladimir Tolmachev, Theodosia Maina, Anna Orlova
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 9, Iss 1, Pp 1-19 (2024)
Abstract Background The gastrin-releasing peptide receptor (GRPR) has been extensively studied as a biomolecular target for peptide-based radiotheranostics. However, the lack of metabolic stability and the rapid clearance of peptide radioligands, inc
Externí odkaz:
https://doaj.org/article/637e1155b147456f8a59fd7e94ba6862
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Karim Obeid, Panagiotis Kanellopoulos, Ayman Abouzayed, Adam Mattsson, Vladimir Tolmachev, Berthold A. Nock, Theodosia Maina, Anna Orlova
Publikováno v:
Pharmaceutics, Vol 16, Iss 4, p 513 (2024)
Gastrin-releasing peptide receptor (GRPR)-antagonists have served as motifs in the development of theranostic radioligands for prostate cancer. Our efforts have been focused on the development of radiolabeled RM26 (H-DPhe6–Gln7–Trp8–Ala9–Val1
Externí odkaz:
https://doaj.org/article/76e700bb020b4623bb32b8e8e73fddd6
Publikováno v:
Frontiers in Nuclear Medicine, Vol 3 (2023)
Externí odkaz:
https://doaj.org/article/3c17d66515864be0af05e4d5c56bbfa5
Autor:
Elmira Yazdani, Parham Geramifar, Najme Karamzade-Ziarati, Mahdi Sadeghi, Payam Amini, Arman Rahmim
Publikováno v:
Diagnostics, Vol 14, Iss 2, p 181 (2024)
Radiotheranostics refers to the pairing of radioactive imaging biomarkers with radioactive therapeutic compounds that deliver ionizing radiation. Given the introduction of very promising radiopharmaceuticals, the radiotheranostics approach is creatin
Externí odkaz:
https://doaj.org/article/54bbac7ea9fa448db738e69ffba96d47
Autor:
Atsushi Yagishita, Miho Katsuragawa, Shin’ichiro Takeda, Yoshifumi Shirakami, Kazuhiro Ooe, Atsushi Toyoshima, Tadayuki Takahashi, Tadashi Watabe
Publikováno v:
Bioengineering, Vol 11, Iss 1, p 25 (2023)
In targeted radionuclide therapy, determining the absorbed dose of the ligand distributed to the whole body is vital due to its direct influence on therapeutic and adverse effects. However, many targeted alpha therapy drugs present challenges for in
Externí odkaz:
https://doaj.org/article/0073714b2049437aa863a030d6c35742